On my independent breast cancer NGS project, I built an end-to-end somatic variant-calling pipeline for tumor-only data aligned to hg38. Filtering reduced high-impact variant calls from 16,691 to 6,982, and I documented the workflow in a public GitHub repository.
I also analyzed RNA-seq data from GPER agonist treatment in MCF-7 breast cancer cells, taking the work from sequencing-data retrieval and quality checks through alignment, gene quantification, differential expression, and GO enrichment. I documented the methodology and reproducibility instructions in a public GitHub repository.
At Naari Pharma Pvt. Ltd., I performed chemical analysis and sampling of raw and packing materials, prepared QC reports, and maintained documentation under GMP, GLP, and SOP requirements. I’m currently completing a certified Bioinformatics Analyst training program.
